ARDIZZONE, SANDRO
 Distribuzione geografica
Continente #
EU - Europa 18.583
NA - Nord America 10.513
AS - Asia 5.277
SA - Sud America 308
OC - Oceania 116
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 18
Totale 34.849
Nazione #
US - Stati Uniti d'America 10.263
GB - Regno Unito 9.215
IT - Italia 3.181
CN - Cina 2.677
DE - Germania 1.582
SE - Svezia 1.319
UA - Ucraina 609
TR - Turchia 562
IN - India 547
IE - Irlanda 544
KR - Corea 479
FR - Francia 445
SG - Singapore 362
RU - Federazione Russa 303
NL - Olanda 266
FI - Finlandia 252
EU - Europa 250
CA - Canada 224
ES - Italia 215
CO - Colombia 188
JP - Giappone 179
DK - Danimarca 135
PL - Polonia 130
HK - Hong Kong 120
ID - Indonesia 114
AU - Australia 96
BE - Belgio 93
BR - Brasile 82
GR - Grecia 69
VN - Vietnam 69
CH - Svizzera 57
PT - Portogallo 31
TW - Taiwan 30
IR - Iran 28
RO - Romania 26
AT - Austria 25
HU - Ungheria 25
MX - Messico 20
NO - Norvegia 19
NZ - Nuova Zelanda 18
IL - Israele 17
SA - Arabia Saudita 15
PH - Filippine 14
UZ - Uzbekistan 14
EG - Egitto 12
AR - Argentina 10
CL - Cile 10
CZ - Repubblica Ceca 9
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
MY - Malesia 6
TH - Thailandia 6
EC - Ecuador 5
JO - Giordania 5
PE - Perù 5
PK - Pakistan 5
SD - Sudan 5
BD - Bangladesh 4
LB - Libano 4
RS - Serbia 4
UG - Uganda 4
HR - Croazia 3
LK - Sri Lanka 3
LT - Lituania 3
LV - Lettonia 3
MA - Marocco 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
AP - ???statistics.table.value.countryCode.AP??? 2
BG - Bulgaria 2
BY - Bielorussia 2
EE - Estonia 2
GT - Guatemala 2
IQ - Iraq 2
IS - Islanda 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PG - Papua Nuova Guinea 2
SI - Slovenia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
KE - Kenya 1
KH - Cambogia 1
KY - Cayman, isole 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
PY - Paraguay 1
QA - Qatar 1
Totale 35.081
Città #
Southend 8.746
Chandler 1.289
Milan 738
Seattle 687
Princeton 623
Beijing 621
Ashburn 598
Wilmington 589
Jacksonville 556
Dublin 535
Fairfield 416
Frankfurt am Main 379
Ann Arbor 378
Dearborn 338
Nanjing 318
Hangzhou 314
Houston 312
Redmond 301
Woodbridge 301
Boardman 245
Somerville 234
Redwood City 220
Des Moines 210
Bengaluru 207
Serra 193
Mountain View 192
Andover 175
Sakarya 168
Singapore 168
Bogotá 166
Rome 147
Toronto 138
Cambridge 130
Phoenix 121
Berlin 119
Shanghai 113
Guangzhou 111
Jinan 97
Nanchang 91
Warsaw 91
New York 88
Hong Kong 86
Shenyang 85
Grafing 78
Istanbul 64
Hebei 62
Changsha 60
Hanover 59
Turin 59
Brussels 57
Sunnyvale 54
Bitonto 52
San Diego 52
Helsinki 50
Tianjin 50
London 49
Jakarta 45
Tokyo 42
Kunming 41
Seoul 41
Fremont 40
Jiaxing 39
Dong Ket 37
Falls Church 36
Ningbo 36
Madrid 35
Verona 35
Zhengzhou 35
Barcelona 34
Bühl 34
Chicago 34
Los Angeles 34
Paris 34
Bologna 32
Palermo 32
Athens 31
Padova 28
Genoa 26
Hefei 26
Wuhan 26
Munich 25
Arese 24
Saint Petersburg 24
São Paulo 24
Medford 23
Amsterdam 21
Haikou 21
Lanzhou 21
Ottawa 21
Roxbury 21
Sydney 21
Taipei 21
Eitensheim 20
Florence 20
Naples 20
Duncan 19
Kiez 19
Central District 18
Cleveland 18
Mumbai 18
Totale 23.632
Nome #
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial 960
Validation of the Italian translation of the Inflammatory bowel disease questionnaire 819
Inflammatory bowel disease phenotype as risk factor for cancer in a prospective multicentre nested case-control IG-IBD Study 557
ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior 497
Totally laparoscopic, multi-stage, restorative proctocolectomy for inflammatory bowel diseases. A prospective study on safety, efficacy and long-term results 360
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus 329
Strictureplasties performed by laparoscopic approach for complicated Crohn's disease. A prospective, observational, cohort study 329
Certolizumab pegol : an evidence-based review of its place in the treatment of Crohn’s disease 327
Autologous hematopoetic stem cell transplantation for refractory Crohn disease a randomized clinical trial 299
Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's Disease : a review on behalf of ECCO and EBMT 293
Increase in chromogranin A- and serotonin-positive cells in pouch mucosa of patients with ulcerative colitis undergoing proctocolectomy 289
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 288
Endoscopic palliation in patients with incurable malignant colorectal obstruction by means of self-expanding metal stent: analysis of results and predictors of outcomes in a large multicenter series 273
Adalimumab in active ulcerative colitis: A "real-life" observational study 255
Small bowel carcinomas in coeliac or Crohn's disease: Clinico-pathological, molecular, and prognostic features : A study from the small bowel cancer Italian consortium 239
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease : Special situations 226
Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn's disease 219
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group 208
Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study 206
Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease 205
Anal endosonographic evaluation of infliximab treatment for perianal fistulizing Crohn's disease 191
Trombofilia e malattie infiammatorie croniche intestinali 189
IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool 187
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up without CD34+ cell selection 184
Noninvasive testing in the management of children with suspected inflammatory bowel disease 179
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement 173
Serum protein profiling of early and advanced stage Crohn's disease 173
Endoscopic retrograde cholangiopancreatography, lights and shadows: Handle with care 173
CARD15 gene variants and risk of reoperation in Crohn's disease patients 173
Power Doppler sonography in the diagnosis of fistulae in complicated Crohn's disease 170
Azathioprine and mesalamine in preventing relapse after conservative surgery for Crohn's disease : results of randomized controlled trial 169
Acute obstruction in Crohn's disease . Results of a multidisciplinary prospective protocol for surgical management 166
An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseases 166
Infliximab nel trattamento del morbo di Crohn fistolizzante : follow-up clinico ed endosonografico 165
Fok 1 vitamin D receptor gene polymorphism does not affect bone mineral density in patients with inflammatory bowel disease 165
Azathioprine is more effective than oral 5-ASA in the treatment of steroid-dependent ulcerative colitis 165
Ultrasonographic detection of toxic megacolon in inflammatory bowel diseases 164
Infliximab-induced lupus in Crohn's disease: a case report 164
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease 162
IBD Year Book 2001 162
Appropriateness and diagnostic yield of colonoscopy in the management of patients with ulcerative colitis : a prospective study in an open access endoscopy service 161
Ruolo dei salicilati nella colite ulcerosa in remissione: prevenzione della recidiva o del cancro colo-rettale? 158
Fistole perianali nella malattia di Crohn : Un approccio pratico al trattamento 158
L'anemia nelle malattie infiammatorie croniche intestinali 157
Prevalence, detection rate and outcome of Cytomegalovirus infection in ulcerative colitis patient requiring colonic resection 157
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD34+ cells selection 156
Contrast radiology, computed tomography (CT) and ultrasonography (US) in detecting abdominal complications of Crohn's disease (CD). A prospective comparative study 156
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 156
Inflammatory colitis: classification and surgical treatment 155
Maintenance treatment with azathioprine in ulcerative colitis : outcomes after drug withdrawal in patients with sustained remission 154
Terapia medica della colite ulcerosa refrattaria 153
Infliximab for the treatment of pyoderma gangrenosum (PG) in steroid-dependent ulcerative colitis (UC): a case report 153
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : a 5-years follow-up inception cohort study 152
Autologous haematopoietic stem cell transplantation for refractory Crohn’s disease: updating the Milan experience without CD34+ cell selection 151
Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease 149
Autologous haematopoietic unselected peripheral blood stem cell transplantation in refractory Crohn's disease: up to 2-years follow-up of a phase I-II trial 149
Prevalence and clinical factors associated with pouchitis in a series of 49 patients with pouch-anal anastomosis 149
Endoscopic full-thickness resection of a submucosal right colon lesion 149
Oral and topical 5-aminosalicylic acid(mesalazine)in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis : one-year randomised multicentre trial 148
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : a 5-years follow-up inception cohort study 148
Efficacy, tolerability and outcome of antiviral therapy in patients affected by hepatitis C and inflammatory bowel disease 148
Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease 147
Morphological and functional evaluation of ileo-pouch-anal-anastomosis for ulcerative colitis by dynamic transperineal ultrasound 147
The time course of diagnostic delay in inflammatory bowel disease over the last sixty years : An Italian multicentre study 147
Extraintestinal manifestations of inflammatory bowel disease 146
Efficacia dell'infliximab nel trattamento a breve termine del morbo di Crohn 145
Infliximab nel trattamento del pioderma gangrenoso nella colite ulcerosa cortico-dipendente 145
Immunomodulatory effects of autologous stem cell transplantation in refractory Cronh’s disease : updatring the Milan experience without CD34+ cell selection 144
Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population 144
MDR1 C3435T polymorphism and susceptibility to inflammatory bowel disease : lack of association in an italian population 143
Autologous non- myeloablative haematopoietic stem cell transplantation without CD34+selection for refractory Crohn's disease: the Milan experience after 5 years 142
Age, and location, but not gender, behaviour, family history and extraintestinal manifestations affect recurrence after conservative surgery for complicated Crohn's disease 142
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD 34+ cells selection 140
Strictureplasty and bowel resection in complicated Crohn's disease. A prospective comparative study on morbidity and long-term recurrence 140
Use of colonoscopy in the management of patients with Crohn's disease: appropriateness and diagnostic yield 140
3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 2: Surgical management and special situations 140
Prevalence and clinical significance of sonographic alteration of mesenteric fat in Crohn's disease 139
Combined therapeutic approach : Inflammatory bowel diseases and peripheral or axial arthritis 139
Autologous stem cell transplantation in moderate-severe refractory Crohn's disease : the Milan experience without CD34+ cells selection 138
Controlled trial of azathioprine and mesalamine in preventing recurrence after conservative surgery for Crohn's disease 138
Vitamin D and inflammatory bowel disease 138
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis 138
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease an IG-IBD study 137
Italian panel for appropriateness of immunosuppressive drugs in inflammatory bowel diseases (IBD): position statement 137
Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on Th1/Th2 cytokines in inflammatory bowel disease : an in vitro study 137
The PROSit cohort of infliximab biosimilar in IBD : a prolonged follow-up on the effectiveness and safety across Italy 137
Prevalence and clinical significance of sonographic detection of enlarged regional lymph nodes in Crohn's disease 136
Osteoporosi e malattie infiammatorie croniche intestinali: sorveglianza e terapia 135
La prevenzione delle complicanze stenotiche nella malattia di Crohn 135
IBD Year Book 2002 135
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alfa treatment 135
Contrast-enhanced ultrasound in the diagnosis of intraabdominal inflammatory masses complicating Crohn's disease 135
L'ecografia intestinale nel morbo di Crohn. Rilevanza chirurgica 134
Maintenance treatment with azathioprine in ulcerative colitis : outcomes after drug withdrawal in patients with sustained remission 134
Colonoscopy surveillance for dysplasia and colorectal cancer in long-standing ulcerative colitis: a cohort Italian study 133
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : mucosal healing as prognostic predictor in a 5-years follow-up inception cohort study 133
Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal 133
Utilità  del pattern ecografico delle pareti intestinali nella valutazione delle caratteristiche istologiche delle stenosi ileali nella malattia di Crohn 132
Infliximab in treatment of Crohn's disease : the Milan experience 132
The impact of timing on the efficacy of foy in the prevention of acute pancreatitis : a randomised study comparing prior vs after-ERCP administration 132
Totale 19.239
Categoria #
all - tutte 81.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019254 0 0 0 0 0 0 0 0 0 0 0 254
2019/20205.517 602 181 197 687 270 878 555 480 690 565 241 171
2020/20215.391 222 597 429 134 431 383 543 285 630 500 853 384
2021/20224.167 322 153 182 332 309 256 319 355 481 525 225 708
2022/20234.964 579 462 388 627 516 878 181 303 542 115 240 133
2023/20243.409 136 262 181 225 714 408 258 337 146 216 361 165
Totale 36.992